Diabetes Research Centers (P30 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for Diabetes Research Centers that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. Diabetes Research Centers support two primary research-related activities: Research Core services and a Pilot and Feasibility (P and F) program.

DIABETES RESEARCH CENTERS

Jonathan S Bogan Jonathan S Bogan Yale University Yale University
Dr. Bogan’s research seeks to understand how glucose uptake is regulated in fat and muscle cells. In these cell types, insulin causes glucose transporters to move from internal membranes to the cell surface. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Christopher Gardner Christopher Gardner PhD Stanford University Stanford University
Dr. Gardner, Professor of Medicine, Stanford Prevention Research Center, has extensive experience in successful study design, recruitment and retention. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Jeffrey E Pessin PhD Albert Einstein College of Medicine Albert Einstein College of Medicine
The Pessin laboratory is analyzing insulin signaling at the molecular level, the regulation of glucose uptake and metabolism at the cellular, molecular level and the integrative systems of metabolism in normal and pathophysiologic states in genetic rodent models. The Einstein-Mount Sinai Diabetes Research Center (ES-DRC) comprises a vibrant, extensive, diverse, well-funded and highly productive program that provides the foundation for high-quality and cutting-edge research in diabetes and related studies in obesity, metabolism and endocrinology.
Andrea L Cherrington Andrea L Cherrington MD MPH University of Alabama at Birmingham University of Alabama at Birmingham
Dr. Cherrington is committed to efforts that bridge the gap between the health care system and underserved communities. Her research focuses on developing, implementing and evaluating community-based interventions to improve the outcomes of disadvantaged populations at high risk for developing chronic disease- specifically diabetes. The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
Julian P Whitelegge Julian P Whitelegge PhD UCSD-UCLA UCSD-UCLA
Julian Whitelegge received his Ph.D. from Imperial College of Science and Technology, University of London in 1989 and became heavily involved in mass spectrometry research in the mid nineties. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Raimund I Herzog Raimund I Herzog MD MHS Yale University Yale University
Dr. Herzog’s laboratory is focused on characterizing and preventing its central nervous complications. He uses state-of-the-art technologies to define the impact of diabetes and intensive insulin treatment on brain metabolism and cognition. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Richard E Ostlund Jr MD Washington University in St Louis Washington University in St Louis
Dr. Richard Ostlund is a professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine in St. Louis. Dr. Ostlund is an acknowledged leader in the field of human cholesterol measurement specializing in general endocrinology, lipid metabolism, diabetes, thyroid disease and nutrition. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Hassan Chaib Hassan Chaib PhD Stanford University Stanford University
In 2011, Dr. Chaib joined the Genetics Department at Stanford University, focusing on next generation sequencing technologies and stem cell therapy of muscular dystrophy. He is currently the Director of Lab Operations for SCGPM and the GSSC and Director of Stem Cell Genomics at the CIRM CESCG. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Fredric Kraemer MD Stanford University Stanford University
Dr. Fredric Kraemer is the Chief of the Division of Endocrinology, Gerontology and Metabolism. He is a board certified endocrinologist for over 35 years who specializes in the treatment diabetes mellitus, particularly type 1 diabetes, and the treatment of lipid disorders, such as elevated cholesterol or triglycerides. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Steven E Kahn MB ChB University of Washington University of Washington
Dr. Kahn received his medical degree from the University of Cape Town, South Africa. He is an endocrinologist whose research focuses on the mechanisms responsible for the critical impairments in insulin secretion that result in the development of diabetes. The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Michael Sturek Michael Sturek PhD Indiana University Indiana University
The general aim of our research program is to understand cellular and molecular Ca signaling mechanisms for in vivo cardiovascular phenomena. The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
Joseph A Baur Joseph A Baur PhD University of Pennsylvania University of Pennsylvania
The Baur lab is interested in the basic mechanisms that lead to aging. Age is the most important risk factor for many of the diseases affecting Western society today, including cancer, cardiovascular disease, and neurodegenerative disorders. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Jeffrey S Elmendorf Jeffrey S Elmendorf PhD Indiana University Indiana University
Dr. Elmendorf's research over the past 20 years has been focused on dissecting mechanisms regulating skeletal muscle and adipose tissue glucose transport and defining their alterations in insulin resistance. The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
Christopher K Glass Christopher K Glass MD PhD UCSD-UCLA UCSD-UCLA
Christopher K. Glass is Professor of Cellular and Molecular Medicine and Professor of Medicine at the University of California, San Diego School of Medicine. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Martin G Myers Jr MD PhD University of Michigan University of Michigan
Dr. Myers’ research focuses on the processes that enable the body to respond normally to insulin, and how problems in these pathways contribute to the development of insulin resistance and diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Mark O Goodarzi MD PhD UCSD-UCLA UCSD-UCLA

The laboratory of Mark O. Goodarzi, MD, PhD, seeks to identify genetic factors underlying conditions related to insulin resistance and the metabolic syndrome, using a population genetic approach.

The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
Yale University Yale Joslin Diabetes Center Joslin 
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes., Nathan, David M., Bebu Ionut, Hainsworth Dean, Klein Ronald, Tamborlane William, Lorenzi Gayle, Gubitosi-Klug Rose, and Lachin John M. , N Engl J Med, 2017 04 20, Volume 376, Issue 16, p.1507-1516, (2017)
NIDDK Center
The Digestive Disease Research Core Centers are part of an integrated program of support for basic and clinical research in digestive and liver diseases. Research in these Centers focuses on the etiology, treatment, and prevention of digestive and/or liver diseases.
Diabetes Resource
T1DBase provides information on human type 1 diabetes loci based on genome build GRCh38. In October 2016, T1DBase merged with ImmunoBase, a web based resource focused on the genetics and genomics of immunologically related human diseases.